199 Biotechnologies
Pre-clinicalFounded by Boris Djordjevic, 199 Biotechnologies pioneers breakthrough therapies to extend healthy human lifespan through partial reprogramming and advanced diagnostics.
Founded
2021
Focus
Synthetic BiologyMetabolic
About
Founded by Boris Djordjevic, 199 Biotechnologies pioneers breakthrough therapies to extend healthy human lifespan through partial reprogramming and advanced diagnostics.
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile